Clinical Trial

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

Study acronym: RESONATE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-14.
Trial Details
NCT Number NCT07594483
Lead Sponsor Motif Neurotech, Inc.
Collaborators: Bright Research Partners
Conditions Major Depressive Disorder
Enrollment 20 participants
Start Date 2026-07
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-06